El-Sheikh et al. already showed that inhibition of Aurora Kinase A enhances the chemosensitivity of medulloblastoma [115], and targeting Aurora Kinase A in combination with HH pathway inhibitors was reported as novel therapeutic strategy in the treatment of human medulloblastoma [92]. Here, AURKA is linked to medulloblastoma.